Icario to Showcase Digital-First Healthcare Innovation at Three Key Industry Events in October
Health Action Leader to Have a Presence at HLTH 2023, MHPA23 and the NCQA Health Innovation SummitMINNEAPOLIS, Sept. 19, 2023...
Health Action Leader to Have a Presence at HLTH 2023, MHPA23 and the NCQA Health Innovation SummitMINNEAPOLIS, Sept. 19, 2023...
RevoMotion™ Reverse Shoulder System showing smallest diameter threaded glenoid baseplate RevoMotion™ Reverse Shoulder System showing smallest diameter threaded glenoid baseplate...
IRVINE, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve...
Cartographer AI Explorer acts as a website assistant for each visitor, providing tailored content, contextualized explanations, and one-on-one guidance, all...
- Research study demonstrates regulation of chromatin structure and cancer gene expression – - Findings to augment clinical trial in...
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023...
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene...
PASADENA, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Nudj Health, a tech-enabled health service that delivers evidence-based mental health and...
The only FDA-cleared multi-target biothreat product developed and manufactured by a U.S. owned companyLEXINGTON, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE)...
FORT LEE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and...
MIAMI, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Nabla and Opus EHR, two trailblazing names in the healthcare technology sector, have...
FLORHAM PARK, N.J. and DRAPER, Utah, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a global technology-led business...
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need Parexel Gwyn Bebb, BM, BCh., Ph.D., Senior Vice...
– Combined proceeds of financing and Orthobiologics divestiture potentially top $60 million – SILVER SPRING, Md., Sept. 19, 2023 (GLOBE...
YONKERS, New York, Sept. 19, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the...
Key learnings include strategies and best practices for leveraging new technologies while maintaining data security, privacy, and compliancePLEASANTON, Calif., Sept....
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel,...
Dedicated team of global regulatory experts delivers submissions in increasingly shorter timelinesPRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Certara,...
MINNEAPOLIS, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the...
Newly granted patents expand the use of the DeltEx Drug Resistant Immunotherapy (DRI) platform to encompass Chimeric Antigen Receptor T-cell...